Free Access
| Issue |
Med Sci (Paris)
Volume 34, Number 1, Janvier 2018
|
|
|---|---|---|
| Page(s) | 24 - 26 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/20183401007 | |
| Published online | 31 January 2018 | |
- Kalemkerian GP. Small cell lung cancer. Semin Respir Crit Care Med 2016; 37 : 783-96. [CrossRef] [PubMed] [Google Scholar]
- Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol 2017; 14 : 549-61. [CrossRef] [Google Scholar]
- Le Caignec C. Pathologies humaines et récepteur Notch. Med Sci (Paris) 2011; 27 : 593-5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 2014; 25 : 318-34. [CrossRef] [PubMed] [Google Scholar]
- Ito T, Udaka N, Yazawa T, et al. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 2000; 127 : 3913-21. [PubMed] [Google Scholar]
- Sriuranpong V, Borges MW, Ravi RK, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001; 61 : 3200-5. [Google Scholar]
- George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer. Nature 2015; 524 : 47-53. [CrossRef] [PubMed] [Google Scholar]
- Jahchan NS, Lim JS, Bola B, et al. Identification and targeting of long-term tumor-propagating cells in small cell lung cancer. Cell Rep 2016; 16 : 644-56. [CrossRef] [PubMed] [Google Scholar]
- Lim JS, Ibaseta A, Fischer MM, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature 2017; 545 : 360-4. [CrossRef] [PubMed] [Google Scholar]
- Chen ZF, Paquette AJ, Anderson DJ. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat Genet 1998; 20 : 136-42. [CrossRef] [PubMed] [Google Scholar]
- Yen WC, Fischer MM, Axelrod F, et al. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Clin Cancer Res 2015; 21 : 2084-95. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.